Surgalign Holdings Inc
XBER:RT2
Net Margin
Surgalign Holdings Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
S
|
Surgalign Holdings Inc
F:RT2
|
20.1m EUR |
-65%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
34.5B CHF |
11%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6.2T JPY |
23%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
136.8B DKK |
16%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
14.2B USD |
10%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF |
12%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP |
8%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
43.1B CNY |
40%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD |
9%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD |
-8%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
17%
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Surgalign Holdings Inc's most recent financial statements, the company has Net Margin of -64.6%.
You don't have any saved screeners yet